Altered Expression of CYSLTR1 is Associated With Adverse Clinical Outcome in Triple Negative Breast Tumors: An In Silico Approach

Objective:Triple negative breast cancer (TNBC) has high relapse rates due to dysregulated inflammatory signaling pathways and significant changes in the tumor microenvironment, probably influencing the failure of several therapies. The Cysteinyl Leukotriene Receptor 1 (CYSLTR1), a leukotriene modula...

Full description

Bibliographic Details

Published in:	European Journal of Breast Health
Main Authors:	Andrés Galindo Céspedes, Mércia Patrícia Ferreira Conceição, aniel Rodrigues de Bastos, Gabriela Ávila de Grazia, Jean Michel Rocha Sampaio Leite, Renan Gomes do Nascimento, Matthew Thomas Ferreira, Rossana Mendoza Lopez
Format:	Article
Language:	English
Published:	Galenos Publishing House 2023-04-01
Subjects:	cysltr1 leukotriene mediators of inflammation triple-negative breast cancer
Online Access:	http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/altered-expression-of-cysltr1-is-associated-with-a/59072